Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126403931 | 12640393 | 1 | I | 20160727 | 20160810 | 20160810 | EXP | GB-AUROBINDO-AUR-APL-2016-10037 | AUROBINDO | 57.00 | YR | M | Y | 0.00000 | 20160810 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126403931 | 12640393 | 1 | PS | Ondansetron | ONDANSETRON | 1 | Unknown | U | U | 78539 | |||||||||
| 126403931 | 12640393 | 2 | SS | TRAMADOL. | TRAMADOL | 1 | Unknown | U | U | 0 | |||||||||
| 126403931 | 12640393 | 3 | SS | 5-FU /00098801/ | FLUOROURACIL | 1 | Unknown | CYCLE 8 DAY 1 | U | U | 0 | ||||||||
| 126403931 | 12640393 | 4 | SS | APREPITANT. | APREPITANT | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126403931 | 12640393 | 5 | SS | ATROPINE. | ATROPINE | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 126403931 | 12640393 | 6 | SS | AVASTIN | BEVACIZUMAB | 1 | Unknown | U | U | 0 | |||||||||
| 126403931 | 12640393 | 7 | SS | BEVACIZUMAB | BEVACIZUMAB | 1 | Unknown | U | U | 0 | |||||||||
| 126403931 | 12640393 | 8 | SS | CALCIUM FOLINATE | LEUCOVORIN CALCIUM | 1 | Unknown | U | U | 0 | |||||||||
| 126403931 | 12640393 | 9 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | U | 0 | |||||||||
| 126403931 | 12640393 | 10 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126403931 | 12640393 | 1 | Product used for unknown indication |
| 126403931 | 12640393 | 2 | Product used for unknown indication |
| 126403931 | 12640393 | 3 | Product used for unknown indication |
| 126403931 | 12640393 | 4 | Product used for unknown indication |
| 126403931 | 12640393 | 5 | Product used for unknown indication |
| 126403931 | 12640393 | 6 | Product used for unknown indication |
| 126403931 | 12640393 | 7 | Product used for unknown indication |
| 126403931 | 12640393 | 8 | Product used for unknown indication |
| 126403931 | 12640393 | 9 | Product used for unknown indication |
| 126403931 | 12640393 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126403931 | 12640393 | OT |
| 126403931 | 12640393 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126403931 | 12640393 | Alopecia | |
| 126403931 | 12640393 | Arthropathy | |
| 126403931 | 12640393 | Change of bowel habit | |
| 126403931 | 12640393 | Decreased appetite | |
| 126403931 | 12640393 | Diarrhoea | |
| 126403931 | 12640393 | Emotional disorder | |
| 126403931 | 12640393 | Fatigue | |
| 126403931 | 12640393 | Gait disturbance | |
| 126403931 | 12640393 | Hypertension | |
| 126403931 | 12640393 | Ill-defined disorder | |
| 126403931 | 12640393 | Mouth ulceration | |
| 126403931 | 12640393 | Muscular weakness | |
| 126403931 | 12640393 | Oral pain | |
| 126403931 | 12640393 | Pain | |
| 126403931 | 12640393 | Pyrexia | |
| 126403931 | 12640393 | Rhinorrhoea | |
| 126403931 | 12640393 | Stoma site pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |